LOGIN  |  REGISTER
Chimerix
C4 Therapeutics

Community Health Systems Completes Divestiture of Cedar Park Regional Medical Center in Texas

July 01, 2025 | Last Trade: US$2.91 0.00 0.00

FRANKLIN, Tenn. / Jul 01, 2025 / Business Wire / Community Health Systems, Inc. (NYSE: CYH) announced today that subsidiaries of the Company have completed the sale of their collective 80% interest in Cedar Park Regional Medical Center and ancillary businesses located in Cedar Park, Texas, to subsidiaries of Ascension Health for $436 million. Ascension Health previously held a minority interest in Cedar Park Regional Medical Center and purchased the remaining interest through this transaction. Contemporaneous with completion of this transaction, subsidiaries of the Company distributed the balance of amounts owed to Cedar Park Regional Medical Center to subsidiaries of Ascension Health in the amount of approximately $23 million. The entry into the definitive agreement for this transaction was announced on April 15, 2025, and the closing was effective June 30, 2025.

About Community Health Systems, Inc.

Community Health Systems, Inc. is one of the nation’s largest healthcare companies. The Company's affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 35 distinct markets across 14 states. The Company's subsidiaries own or lease 70 affiliated hospitals with more than 10,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers.

The Company’s headquarters are located in Franklin, Tennessee, a suburb south of Nashville. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.” More information about the Company can be found on its website at www.chs.net.

C4 Therapeutics

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page